FDA clears Sine Health app that tracks essential tremor using only a smartphone
Sine Health said on November 17 that the FDA cleared Sine, a smartphone app that measures essential tremor from the phone's own sensors during daily life, under 510(k) K261026.
Docket, covering health regulation and AI in care
, 2 min read
K261026the FDA 510(k) number for Sine
What to know
- The FDA granted 510(k) clearance K261026 to Sine, a smartphone-based essential tremor monitoring system, according to Sine Health.
- The app runs in the background and measures tremor passively with sensors already in the phone, the company said.
- It is the Stockholm company's second FDA clearance; its first, in June 2026, covered Parkinson's monitoring on the Apple Watch.
Stockholm-based Sine Health said on November 17 that the U.S. Food and Drug Administration has granted 510(k) clearance (K261026) to Sine, a system that monitors essential tremor using only a smartphone. The company calls it the first FDA-cleared way to do that. All details here come from the company's release on PR Newswire; we found no independent report and could not yet read the FDA's own record for K261026.
What the app does
Essential tremor is a nerve condition that causes rhythmic shaking, most often of the hands. It is common: the company puts the number of affected Americans at about 7 million. Doctors usually judge severity by watching a patient perform tasks during a clinic visit, which captures only a few minutes of a condition that changes through the day.
Sine runs as a background app and measures tremor passively from motion sensors already built into the phone while the person goes about daily life, according to the release. The aim is to give clinicians an objective record of how tremor behaves between appointments. The company did not give a launch date, a price, or details of the clinical testing behind the clearance in the material we could read.
The company's second clearance
Sine Health, which the release says was formerly known as Nordic Kinetics, describes its work as AI-based neurological assessment from smartphone and wearable sensor data. This is its second FDA clearance since it was founded last year; the first, in June 2026, covered a Parkinson's disease monitoring system on the Apple Watch.
Smartwatch and phone tools for movement disorders have been arriving steadily. In September the FDA cleared Kneu Health's Apple Watch tool for tracking Parkinson's symptoms. The "first" claim for a smartphone-only essential tremor monitor is the company's, and we have not verified it against FDA's database.
What a 510(k) means here
A 510(k) clearance means the FDA found the device substantially equivalent to one already legally sold. It is not an approval, and it does not show that monitoring changes treatment or outcomes. Our explainer on clearance, approval and De Novo covers the difference, and our guide to reading a 510(k) summary explains where the FDA posts the testing details once the file is public. Whether such software counts as a medical device at all is a separate question, covered in our piece on general wellness products and wearables.
Why it matters
If it works as described, a phone people already carry could replace a few minutes of clinic observation with a continuous record of tremor, which matters for adjusting medication and judging treatments such as surgery. For now the evidence is the company's announcement; the FDA's 510(k) summary will show what testing the clearance rests on.
This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.
Sources
- Sine Health Receives FDA 510(k) Clearance for the First Smartphone Essential Tremor Monitoring Device, Sine Health via PR Newswire, November 17, 2026
FDA and health regulationDigital health and AI in care
Written by an AI correspondent under standards set by editor Jacob Knight. Spotted an error? Tell us and we will fix it.